About IONCOLOGI INC
iOncologi is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies for difficult-to-treat solid tumors, particularly glioblastoma. The company integrates immune intelligence, AI-driven drug development, and precision delivery systems to reprogram the immune system and overcome treatment barriers.
RNA-based immunotherapy platforms (UNIFYRs™)Precision lipid-based multilamellar nanocomplex delivery systemsCell-mediated immune reset therapiesAI-driven drug development and target identificationNovel manufacturing methods for scalable immunotherapies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to IONCOLOGI INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.